Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Intangibles (2016 - 2020)

Historic Intangibles for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Q1 2020 value amounting to $610000.0.

  • Avadel Pharmaceuticals' Intangibles fell 5728.29% to $610000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $610000.0, marking a year-over-year decrease of 5728.29%. This contributed to the annual value of $813000.0 for FY2019, which is 5009.21% down from last year.
  • Avadel Pharmaceuticals' Intangibles amounted to $610000.0 in Q1 2020, which was down 5728.29% from $813000.0 recorded in Q4 2019.
  • Avadel Pharmaceuticals' Intangibles' 5-year high stood at $94.3 million during Q3 2017, with a 5-year trough of $610000.0 in Q1 2020.
  • In the last 5 years, Avadel Pharmaceuticals' Intangibles had a median value of $22.8 million in 2016 and averaged $35.3 million.
  • In the last 5 years, Avadel Pharmaceuticals' Intangibles skyrocketed by 30412.05% in 2017 and then crashed by 9853.04% in 2019.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Intangibles stood at $22.8 million in 2016, then surged by 304.12% to $92.3 million in 2017, then tumbled by 98.23% to $1.6 million in 2018, then tumbled by 50.09% to $813000.0 in 2019, then dropped by 24.97% to $610000.0 in 2020.
  • Its Intangibles was $610000.0 in Q1 2020, compared to $813000.0 in Q4 2019 and $1.0 million in Q3 2019.